Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BXP market cap is 153.91M. The company's latest EPS is BDT and P/E is N/A.
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BDT (BDT) | BDT (BDT) | BDT (BDT) | BDT (BDT) | BDT (BDT) | |
| Total Revenue | 22.82B | 25.61B | 29.49B | 34.67B | 39.27B |
| Operating Income | 5.04B | 5.99B | 7.09B | 6.9B | 7.22B |
| Net Income | 3.03B | 3.51B | 5.13B | 5.12B | 4.61B |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BDT (BDT) | BDT (BDT) | BDT (BDT) | BDT (BDT) | BDT (BDT) | |
| Total Assets | 49.21B | 50.12B | 52.25B | 66.15B | 69.16B |
| Total Liabilities | 19.35B | 17.32B | 14.88B | 21.51B | 21.54B |
| Total Equity | 29.86B | 32.8B | 37.36B | 44.64B | 47.62B |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BDT (BDT) | BDT (BDT) | BDT (BDT) | BDT (BDT) | BDT (BDT) | |
| Operating | 2.96B | 5.54B | 6.02B | 5.21B | 6.08B |
| Investing | -4.51B | -1.95B | -2.52B | -7.68B | -2.62B |
| Financing | 1.77B | -3.57B | -3.46B | 2.62B | -3.56B |
| Market Cap | 153.91M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 446.11M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 3 (8.33%) |
| Company Name | Beximco Pharma |
| Address |
17 dhanmondi r/a, road no. 2 dhaka city 1205 |
| Website | https://www.beximcopharma.com |
| Industry | pharmaceutical generic (H22) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
